Publication:
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: A phase II study

Simple item page
dc.contributor.authorsStoter, G.; Akdas, A.; Fosså, S.D.; Kaye, S.B.; van Groeningen, C.J.; Renard, J.; van Glabbeke, M.
dc.date.accessioned2022-03-02T05:35:03Z
dc.date.accessioned2026-01-11T05:58:45Z
dc.date.available2022-03-02T05:35:03Z
dc.date.issued1992-07
dc.identifier.doi10.1093/oxfordjournals.annonc.a058266
dc.identifier.issn9237534
dc.identifier.issue7
dc.identifier.pages577-578
dc.identifier.urihttps://hdl.handle.net/11424/218138
dc.identifier.volume3
dc.language.isoeng
dc.relation.urihttps://linkinghub.elsevier.com/retrieve/pii/S0923753419653020
dc.titleHigh-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: A phase II study
dc.title.alternativeHigh-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
129.78 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları